Andyrdj said:This is a nice complement to the other story I spotted regarding "Cell printing" - a layer of harmonically beating cells in a Petri dish extruded by a nozzle.
This article, if I read it right (please research and find more!), might seem to have succeeded in creating a beating chamber. Growing it inside the human body seems to be an added bonus.
Seems to me the two technologies could potentially combine nicely. It's relation to valves is not immediately obvious, though I suspect it will stimulate further research into the growth of durable tissue valves in conjuntion with the main aim of growing a fully functional heart.
Certainly there'll be no shortage of volunteers to test it, given the chronic shortage in available donor hearts.
Andyrdj said:When I went for my last op, my dad tried to encourage me by saying "just think what'll be around in 10 years when you need the next"
At that time tissue valves were lasting around 10 years maximum. But I think he and I secretly hoped that all valve work would be percutaneous by now.
Andyrdj said:When I went for my last op, my dad tried to encourage me by saying "just think what'll be around in 10 years when you need the next"
At that time tissue valves were lasting around 10 years maximum. But I think he and I secretly hoped that all valve work would be percutaneous by now.
There was never an implication made that coumadin is FREE of risk. Just to take my response as an example - I only wanted Andy to be careful of words that might be construed to mean that a life on coumadin is of questionable quality. The 1% risk for coumadin to aggravate an accident resulting in death or cause a stroke is not cumulative. Therefore, in any given year, I have less of a chance of death than someone undergoing OHS. I have lived longer on coumadin than the time frame for a reop (25 years vs 15-20) so I am way ahead of the game. There are many, many people out there in this party boat with me. We also have to be mindful of the fact that mortality and even other complications rates can increase with reops so, just because someone's first surgery was a "breeze" doesn't mean that their second (or third) will be the same. I can personally attest to that despite any stats or reports out there because I have been through it.OldManEmu said:While I believe Andy is overly optimistic, the long term stats do not show ACT free of risk, the long term average is 1% per patient year of a bad event while on ACT. The 1% is death or stroke with permanent damage this is not to be dismissed. Over the long term both risks are fairly similar. It just depends which way you want it, slow and constant or every 15 years, I think this depends on personality type. Life style issues also play a part if you take part in activities that carry a real risk of concussion with or without a helmet ACT carries increased risk. Here are a couple of studies in AVR redos http://www.ncbi.nlm.nih.gov/entrez/...ve&db=PubMed&list_uids=15138098&dopt=Abstract The second is from a paper presented at the Canadian Cardiovascular Congress 2003 http://www.pulsus.com/ccc2003/abs/a417.htm I have not done that much research on MVR's as these are not of personal interest to me, however from what I have read MVR first or redos are more risky than AVRs. The risks with reoperation while real are greatly dependent on co-morbidities as much as the reoperation itself. Lets hope in the long term this tissue engineering research is a success, however I am not placing my hopes on it being available when I require my redo.
Enter your email address to join: